Literature DB >> 17180669

[Adult-onset neuronal ceroid lipofuscinosis].

H J Gdynia1, A D Sperfeld, A C Ludolph.   

Abstract

Neuronal ceroid lipofuscinoses are a heterogenous group of genetic progressive neurodegenerative disorders. Curative therapeutic strategies are not known. These are largely diseases of childhood; adult-onset forms are rare and poorly characterized. The classical adult variant is CLN4 (Kufs' disease), in which autosomal-recessive and autosomal dominant forms are known. Furthermore the "classic infantile" CLN1, caused by a deficiency of the enzyme palmitoylprotein-thioesterase, may be of adult onset Neuronal ceroid lipofuscinoses in adulthood are multifaceted diseases. Their clinical picture is mainly characterized by progressive dementia, seizures, and extrapyramidal motor symptoms. In contrast to the infantile forms, visual loss is an uncommon feature that appears only in adult CLN1 but not CLN4, which may be helpful in clinical differential diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17180669     DOI: 10.1007/s00115-006-2222-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  24 in total

1.  A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7.

Authors:  R B Wheeler; J D Sharp; W A Mitchell; S L Bate; R E Williams; B D Lake; R M Gardiner
Journal:  Mol Genet Metab       Date:  1999-04       Impact factor: 4.797

Review 2.  Clinical features and molecular genetic basis of the neuronal ceroid lipofuscinoses.

Authors:  R Mark Gardiner
Journal:  Adv Neurol       Date:  2002

3.  Central nervous system lipidosis in an adult with atrophy of the cerebellar granular layer: a case report.

Authors:  D I FINE; K D BARRON; A HIRANO
Journal:  J Neuropathol Exp Neurol       Date:  1960-07       Impact factor: 3.685

4.  A dominant form of neuronal ceroid-lipofuscinosis.

Authors:  D H Boehme; J C Cottrell; S C Leonberg; W Zeman
Journal:  Brain       Date:  1971       Impact factor: 13.501

5.  Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.

Authors:  Robert Steinfeld; Peter Heim; Henning von Gregory; Kerstin Meyer; Kurt Ullrich; Hans H Goebel; Alfried Kohlschütter
Journal:  Am J Med Genet       Date:  2002-11-01

6.  Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease.

Authors:  O P van Diggelen; S Thobois; C Tilikete; M T Zabot; J L Keulemans; P A van Bunderen; P E Taschner; M Losekoot; Y V Voznyi
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

7.  Familial Kufs' disease presenting as a progressive myoclonic epilepsy.

Authors:  B Sadzot; M Reznik; J E Arrese-Estrada; G Franck
Journal:  J Neurol       Date:  2000-06       Impact factor: 4.849

8.  Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2).

Authors:  O P Van Diggelen; J L Keulemans; W J Kleijer; S Thobois; C Tilikete; Y V Voznyi
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

9.  An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Authors:  Subrata Chattopadhyay; Masumi Ito; Jonathan D Cooper; Andrew I Brooks; Timothy M Curran; James M Powers; David A Pearce
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

10.  Neuronal ceroid lipofuscinosis: a clinicopathological study.

Authors:  Sanjib Sinha; P Satishchandra; Vani Santosh; N Gayatri; S K Shankar
Journal:  Seizure       Date:  2004-06       Impact factor: 3.184

View more
  1 in total

Review 1.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.